We are pleased to announce the participation of Fabio Efficace, Head of the GIMEMA Health Outcomes Research Unit, at the 10th Translational Research Conference: Myelodysplastic Syndromes, MDS/MPN and Clonal Haematopoiesis, organized by the European School of Haematology (ESH).
The conference will take place from 16 to 18 October 2026 in Malahide, Dublin, Ireland.
During the meeting, Fabio Efficace will deliver the presentation:
“Asking the patient about benefits of treatment in myelodysplastic syndromes”
He will also lead the “Quality of Life PROs” session as part of the Meet the Expert Session.
This conference represents an important opportunity to highlight the role of Patient-Reported Outcomes (PROs) and quality of life in assessing treatment benefits in myelodysplastic syndromes, further strengthening the integration of the patient perspective into clinical research and practice.